Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply: Are CHCHD10 mutations indeed associated with familial amyotrophic lateral sclerosis?
Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K, Berg-Alonso L, Kageyama Y, Serre V, Moore D, Verschueren A, Rouzier C, Le Ber I, Augé G, Cochaud C, Lespinasse F, N'Guyen K, de Septenville A, Brice A, Yu-Wai-Man P, Sesaki H, Pouget J, Paquis-Flucklinger V. Bannwarth S, et al. Among authors: verschueren a. Brain. 2014 Dec;137(Pt 12):e314. doi: 10.1093/brain/awu300. Epub 2014 Oct 27. Brain. 2014. PMID: 25348633 Free PMC article. No abstract available.
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, González-Duarte A, Gillmore JD, Low SC, Sekijima Y, Obici L, Chen C, Badri P, Arum SM, Vest J, Polydefkis M; HELIOS-A Collaborators. Adams D, et al. Amyloid. 2023 Mar;30(1):1-9. doi: 10.1080/13506129.2022.2091985. Epub 2022 Jul 23. Amyloid. 2023. PMID: 35875890 Clinical Trial.
Real-life effectiveness 1 year after switching to avalglucosidase alfa in late-onset Pompe disease patients worsening on alglucosidase alfa therapy: A French cohort study.
Tard C, Bouhour F, Michaud M, Beltran S, Fournier M, Demurger F, Lagrange E, Nollet S, Sacconi S, Noury JB, Magot A, Cintas P, Renard D, Deibener-Kaminsky J, Lefeuvre C, Davion JB, Salort-Campana E, Arrassi A, Taouagh N, Spinazzi M; Pompe Study Group; Attarian S, Laforêt P. Tard C, et al. Eur J Neurol. 2024 Jul;31(7):e16292. doi: 10.1111/ene.16292. Epub 2024 Apr 8. Eur J Neurol. 2024. PMID: 38587143 Free PMC article.
[Lewis and Sumner syndrome].
Pouget J, Verschueren A, Azulay JP, Attarian S. Pouget J, et al. Among authors: verschueren a. Rev Neurol (Paris). 2001 Dec;157(12):1561-4. Rev Neurol (Paris). 2001. PMID: 11924457 French. No abstract available.
[Guillain-Barré syndrome and its frontiers].
Azulay JP, Verschueren A, Attarian S, Pouget J. Azulay JP, et al. Among authors: verschueren a. Rev Neurol (Paris). 2002 Dec;158(123):21-26. Rev Neurol (Paris). 2002. PMID: 12690329 French.
[Guillain-Barre syndrome and its frontiers].
Azulay JP, Verschueren A, Attarian S, Pouget J. Azulay JP, et al. Among authors: verschueren a. Rev Neurol (Paris). 2002 Dec;158(12 Pt 2):S21-6. Rev Neurol (Paris). 2002. PMID: 12690657 Review. French.
Lewis-Sumner syndrome and multifocal motor neuropathy.
Verschueren A, Azulay JP, Attarian S, Boucraut J, Pellissier JF, Pouget J. Verschueren A, et al. Muscle Nerve. 2005 Jan;31(1):88-94. doi: 10.1002/mus.20236. Muscle Nerve. 2005. PMID: 15536613
[Assessment of dysarthria and dysphagia in ALS patients].
Robert D, Bianco-Blache A, Spezza C, Verschueren A, Pouget J, Giovanni A. Robert D, et al. Among authors: verschueren a. Rev Neurol (Paris). 2006 Apr;162(4):445-53. doi: 10.1016/s0035-3787(06)75035-4. Rev Neurol (Paris). 2006. PMID: 16585905 Review. French.
119 results